Molecular genetics of Alzheimer's disease: what have we learned?

Citation
G. Van Gassen et C. Van Broeckhoven, Molecular genetics of Alzheimer's disease: what have we learned?, ACT NEUR BE, 100(2), 2000, pp. 65-76
Citations number
105
Categorie Soggetti
Neurology
Journal title
ACTA NEUROLOGICA BELGICA
ISSN journal
03009009 → ACNP
Volume
100
Issue
2
Year of publication
2000
Pages
65 - 76
Database
ISI
SICI code
0300-9009(200006)100:2<65:MGOADW>2.0.ZU;2-R
Abstract
Alzheimer's disease (AD), by fur the most common form of dementia in the el derly, is clinically characterized by gradual, progressive loss in cognitiv e functioning and changes in personality, ultimately leading to death. It i s now well established that genetic factors play an important role in AD. S o far three genes have been identified in which mutations cause autosomal-d ominant AD : the amyloid precursor protein (APP) gene on chromosome 21, the presenilin I (PSEN1) gene on chromosome 14, and the homologous presenilin 2 (PSEN2) gene on chromosome 1. A major susceptibility gene, the apolipopro tein E (APOE) gene, was identified on chromosome 19.